Free Trial

Bio-Techne (TECH) News Today

Bio-Techne logo
$61.08 +0.01 (+0.01%)
As of 10:34 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Shares Bought by Summit Creek Advisors LLC
Summit Creek Advisors LLC lifted its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 19.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 308,311 shares of the biotechnology company's stock after purchasing an additional 50,881 shares
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Shares Bought by Sei Investments Co.
Sei Investments Co. lifted its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 6.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 563,157 shares of the biotechnology compa
Bio-Techne highlights advances in detection of biomarkers using RNAscope
2 High-Flying Stocks to Target This Week and 1 to Brush Off
Bio-Techne Co. stock logo
Royal London Asset Management Ltd. Grows Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)
Royal London Asset Management Ltd. lifted its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 17.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 67,306 shares of the biotechnology company's stock after
Bio-Techne Co. stock logo
20,085 Shares in Bio-Techne Co. (NASDAQ:TECH) Bought by Fox Run Management L.L.C.
Fox Run Management L.L.C. acquired a new stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 20,085 shares of the biotechnology company's stock, valued at approx
Bio-Techne Co. stock logo
Semanteon Capital Management LP Takes $758,000 Position in Bio-Techne Co. (NASDAQ:TECH)
Semanteon Capital Management LP bought a new position in Bio-Techne Co. (NASDAQ:TECH - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 10,525 shares of the biotechnology company's stock, valued at approximat
Bio-Techne Co. stock logo
Thrivent Financial for Lutherans Sells 5,510 Shares of Bio-Techne Co. (NASDAQ:TECH)
Thrivent Financial for Lutherans reduced its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 3.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 165,838 shares of the biotechnology company'
Bio-Techne Co. stock logo
Broadcrest Asset Management LLC Cuts Stock Position in Bio-Techne Co. (NASDAQ:TECH)
Broadcrest Asset Management LLC trimmed its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 50.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 100,000 shares of the biotechnology company's stock after s
Bio-Techne Co. stock logo
Wilkins Investment Counsel Inc. Has $1.73 Million Stake in Bio-Techne Co. (NASDAQ:TECH)
Wilkins Investment Counsel Inc. raised its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 40.0% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 23,990 shares of the biotechnology company's stock after purchasing an additional 6,850 shares durin
Bio-Techne Co. stock logo
Natixis Advisors LLC Increases Position in Bio-Techne Co. (NASDAQ:TECH)
Natixis Advisors LLC grew its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 7.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 169,681 shares of the biotechnology company
Bio-Techne Co. stock logo
Evercore ISI Begins Coverage on Bio-Techne (NASDAQ:TECH)
Evercore ISI initiated coverage on Bio-Techne in a research note on Tuesday. They issued an "outperform" rating and a $75.00 price target on the stock.
Bio-Techne (NASDAQ:TECH) Now Covered by Evercore ISI
Bio-Techne initiated with an Outperform at Evercore ISI
Bio-Techne Co. stock logo
William Blair Investment Management LLC Has $77.42 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH)
William Blair Investment Management LLC lowered its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 3.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,074,883 shares of the biotechnology company's stock after selling 35,352 share
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Holdings Reduced by Corient Private Wealth LLC
Corient Private Wealth LLC lessened its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 6.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 598,918 shares of the biotechnology com
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. grew its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 317.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 136,243 shares of the biotechnology company's stock after purchasing an additional 103,62
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Holdings Lowered by Swiss National Bank
Swiss National Bank lowered its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 4.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 448,100 shares of the biotechnology company's stock after sel
Bio-Techne Co. stock logo
StockNews.com Upgrades Bio-Techne (NASDAQ:TECH) to "Buy"
StockNews.com raised shares of Bio-Techne from a "hold" rating to a "buy" rating in a report on Tuesday.
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Stock Holdings Lowered by Polen Capital Management LLC
Polen Capital Management LLC cut its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 24.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 20,760 shares of the biotechnology company's stock after sell
Bio-Techne Co. stock logo
Royce & Associates LP Purchases 15,353 Shares of Bio-Techne Co. (NASDAQ:TECH)
Royce & Associates LP grew its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 860,751 shares of the biotechnolog
Bio-Techne Co. stock logo
Wealthfront Advisers LLC Invests $488,000 in Bio-Techne Co. (NASDAQ:TECH)
Wealthfront Advisers LLC bought a new position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,772 shares of the biotechnology company's stock, valued at a
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Tredje AP fonden
Tredje AP fonden reduced its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 50.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,333 shares of the biotechnology company's stock after sell
Bio-Techne Co. stock logo
Hilton Capital Management LLC Boosts Stake in Bio-Techne Co. (NASDAQ:TECH)
Hilton Capital Management LLC grew its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 23.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,414 shares of the biotechnology company's stock after purchasing an additi
Bio-Techne Co. stock logo
21,170 Shares in Bio-Techne Co. (NASDAQ:TECH) Acquired by Postrock Partners LLC
Postrock Partners LLC bought a new position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 21,170 shares of the biotechnology company's stock, valu
Bio-Techne Co. stock logo
Amundi Purchases 116,331 Shares of Bio-Techne Co. (NASDAQ:TECH)
Amundi lifted its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 72.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 277,925 shares of the biotechnology company's stock after
Bio-Techne named short-term buy idea at Deutsche Bank
Bio-Techne Co. stock logo
Bio-Techne (NASDAQ:TECH) Shares Down 6.9% - Should You Sell?
Bio-Techne (NASDAQ:TECH) Trading Down 6.9% - Time to Sell?
Bio-Techne Co. stock logo
Bio-Techne (NASDAQ:TECH) Reaches New 52-Week Low - Here's What Happened
Bio-Techne (NASDAQ:TECH) Hits New 52-Week Low - Time to Sell?
Bio-Techne Co. stock logo
13,336 Shares in Bio-Techne Co. (NASDAQ:TECH) Acquired by Edgestream Partners L.P.
Edgestream Partners L.P. acquired a new stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 13,336 shares of the biotechnology company's stock, valued at approximately $961,000. Other institutional
Bio-Techne Co. stock logo
617,508 Shares in Bio-Techne Co. (NASDAQ:TECH) Acquired by Raymond James Financial Inc.
Raymond James Financial Inc. purchased a new position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 617,508 shares of the biotechnology company's stock, valu
Bio-Techne Co. stock logo
Bio-Techne (NASDAQ:TECH) Lowered to Hold Rating by StockNews.com
StockNews.com cut shares of Bio-Techne from a "buy" rating to a "hold" rating in a research report on Monday.
Bio-Techne Co. stock logo
GC Wealth Management RIA LLC Takes $805,000 Position in Bio-Techne Co. (NASDAQ:TECH)
GC Wealth Management RIA LLC purchased a new stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 11,172 shares of the biotechnology compa
Bio-Techne Co. stock logo
OFI Invest Asset Management Buys New Position in Bio-Techne Co. (NASDAQ:TECH)
OFI Invest Asset Management bought a new stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 15,500 shares of the biotechnology company's stock, valued at approximately $1,078,000. Several other hedg
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Bio-Techne Co. (NASDAQ:TECH - Get Free Report) has been given an average rating of "Moderate Buy" by the eight research firms that are covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to
Bio-Techne Co. stock logo
Charles Schwab Investment Management Inc. Acquires 51,687 Shares of Bio-Techne Co. (NASDAQ:TECH)
Charles Schwab Investment Management Inc. lifted its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,465,690 shares of the biotechnology c
Bio-Techne Co. stock logo
Bank Julius Baer & Co. Ltd Zurich Boosts Position in Bio-Techne Co. (NASDAQ:TECH)
Bank Julius Baer & Co. Ltd Zurich raised its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 14.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 137,131 shares of the biotechnology company's stock after purc
Bio-Techne Co. stock logo
Geneva Capital Management LLC Sells 14,375 Shares of Bio-Techne Co. (NASDAQ:TECH)
Geneva Capital Management LLC reduced its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,089,935 shares of the biotechnology company's stock
Bio-Techne Co. stock logo
Citigroup Lowers Bio-Techne (NASDAQ:TECH) Price Target to $70.00
Citigroup decreased their target price on Bio-Techne from $80.00 to $70.00 and set a "neutral" rating on the stock in a report on Tuesday.
Bio-Techne Co. stock logo
Bio-Techne (NASDAQ:TECH) Reaches New 12-Month Low After Analyst Downgrade
Bio-Techne (NASDAQ:TECH) Hits New 52-Week Low Following Analyst Downgrade
Bio-Techne price target lowered to $70 from $80 at Citi
Remove Ads
Get Bio-Techne News Delivered to You Automatically

Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter.

TECH Media Mentions By Week

TECH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TECH
News Sentiment

1.01

0.63

Average
Medical
News Sentiment

TECH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TECH Articles
This Week

20

9

TECH Articles
Average Week

Remove Ads
Get Bio-Techne News Delivered to You Automatically

Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TECH) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners